Prescription drugs (1 - 10 of 11 items) in Past Year
Drug Safety: FDA Has Improved Its Foreign Drug Inspection Program, but Needs to Assess the Effectiveness and Staffing of Its Foreign Offices
GAO-17-143: Published: Dec 16, 2016. Publicly Released: Jan 17, 2017.
Prescription Drug Labels: Actions Needed to Increase Awareness of Best Practices for Accessible Labels for Individuals Who are Blind or Visually Impaired
GAO-17-115: Published: Dec 9, 2016. Publicly Released: Dec 9, 2016.
Drug Compounding: FDA Has Taken Steps to Implement Compounding Law, but Some States and Stakeholders Reported Challenges
GAO-17-64: Published: Nov 17, 2016. Publicly Released: Nov 17, 2016.
Highlights of a Forum: Preventing Illicit Drug Use
GAO-17-146SP: Published: Nov 14, 2016. Publicly Released: Nov 15, 2016.
Generic Drugs Under Medicare: Part D Generic Drug Prices Declined Overall, but Some Had Extraordinary Price Increases
GAO-16-706: Published: Aug 12, 2016. Publicly Released: Sep 12, 2016.
Physician-administered Drugs: Comparison of Payer Payment Methodologies
GAO-16-780R: Published: Aug 1, 2016. Publicly Released: Aug 31, 2016.
Medicare Part B: Data on Coupon Discounts Needed to Evaluate Methodology for Setting Drug Payment Rates
GAO-16-643: Published: Jul 27, 2016. Publicly Released: Aug 26, 2016.
Medicare Part B: CMS Should Take Additional Steps to Verify Accuracy of Data Used to Set Payment Rates for Drugs
GAO-16-594: Published: Jul 1, 2016. Publicly Released: Aug 1, 2016.
Drug Shortages: Certain Factors Are Strongly Associated with This Persistent Public Health Challenge
GAO-16-595: Published: Jul 7, 2016. Publicly Released: Jul 7, 2016.
Medical Product Oversight: FDA Needs More Strategic Planning to Guide Its Scientific Initiatives
GAO-16-432: Published: May 16, 2016. Publicly Released: Jun 15, 2016.